Trump says AstraZeneca will lower drug prices in US

Contributing sentiments towards policy:

60% : Furthermore, AstraZeneca will invest $50 billion in the United States over the next five years for research and development of new drugs and to onshore manufacturing facilities across the country.
50% : "AstraZeneca, the largest pharmaceutical manufacturer in the United Kingdom, is committing to offer Americans major discounts on their vast catalog of prescription drugs, one of the great companies, by the way, and a most favored nation's pricing clause," said Trump.
50% : Trump explained that similar drugs are sold at much more affordable prices in different countries, whereas prices in the US are high.
50% : " Trump announced Sept. 30 that Pfizer would lower the prices of its drugs sold in the US.
49% : In a news conference at the White House, Trump noted that reducing drug prices was one of the most important agenda items of his presidency, pointing out that Americans have paid the "highest prices anywhere in the world" for drugs.

*Our bias meter rating uses data science including sentiment analysis, machine learning and our proprietary algorithm for determining biases in news articles. Bias scores are on a scale of -100% to 100% with higher negative scores being more liberal and higher positive scores being more conservative, and 0% being neutral. The rating is an independent analysis and is not affiliated nor sponsored by the news source or any other organization.